Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
IN |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
IMI PLC
OTC:IMIUY
|
UK |
|
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
ZA |
Intrinsic Value
Is SUNPHARMA undervalued or overvalued?
See the intrinsic value estimate for Sun Pharmaceutical Industries Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SUNPHARMA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with SUNPHARMA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sun Pharmaceutical Industries Does
Sun Pharmaceutical Industries is a drug maker. It develops, manufactures, and sells prescription medicines, over-the-counter products, and active pharmaceutical ingredients, which are the core chemical ingredients used in making drugs. Its lineup includes generic medicines as well as branded specialty treatments for conditions such as skin diseases, eye care, and chronic illnesses.
- Headquarters
- India IN
- Employees
- 43 000
- IPO date
- Jan 1, 1994
Sun Pharmaceutical Industries has a narrow economic moat
Legal protection for selected medicines prevents rivals from selling direct copies, giving Sun Pharma room to earn profits beyond those available from ordinary generic drugs. This protection applies to part of its portfolio, while its broader generic business faces substantial competition.
Read the full moat analysis
Revenue & Expenses Breakdown
Sun Pharmaceutical Industries Ltd
Earnings Waterfall
Sun Pharmaceutical Industries Ltd
The intrinsic value for Sun Pharmaceutical Industries Ltd (SUNPHARMA) under the Base Case is hidden INR.
Compared with the current market price of 1 743 INR, the stock appears hidden.